Efficient ΦC31 integrase–mediated site-specific germline transformation of Anopheles gambiae by Lycett, Gareth
 1
 
 Efficient phiC31 integrase-mediated site-specific germ-line transformation of Anopheles 
gambiae 
 
Emilie Pondeville1, Nicolas Puchot1, Janet Meredith2, Amy Lynd3, Kenneth Vernick1, 
Gareth Lycett3,a, Paul Eggleston2,a, Catherine Bourgouin1,a 
1Institut Pasteur, Genetics and Genomics of Insect Vectors, CNRS Unit URA3012, Paris, 
France 
2Centre for Applied Entomology and Parasitology, School of Life Sciences, Keele University, 
Keele, UK 
3Department of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, UK 
 
 
a : equal contribution 
 
Catherine Bourgouin, cabourg@pasteur.fr ; Emilie Pondeville, emilie.pondeville@gmail.com 
; Nicolas Puchot, nicolas.puchot@pasteur.fr ; Kenneth D Vernick, 
kenneth.vernick@pasteur.fr : Genetics and Genomics of Insect Vectors, Institut Pasteur, 28 
Rue du Dr Roux, 75015 Paris, France 
Janet Meredith, j.m.meredith@keele.ac.uk ; Paul Eggleston, p.eggleston@keele.ac.uk: 
Institute for Science and Technology in Medicine, School of Life Sciences, Keele University, 
Keele, Staffordshire, ST5 5BG, UK 
Gareth J Lycett, gjlycett@liv.ac.uk, Amy Lynd, amylynd@liv.ac.uk ; Department of Vector 
Biology, Liverpool School of Tropical Medicine, Liverpool, L3 5QA UK 
 
Correspondence to Catherine Bourgouin, tel +33-1-45-68-82-24; Fax: +33-1-40-61-31-10 or 
Emilie Pondeville, tel +33-1-45-68-30-84; Fax: +33 -1- 40-61-31-10 
 
Keywords: Anopheles gambiae, phiC31, site-specific recombination, transgenics 
Supporting primary papers: 
Meredith et al., 2011,  
Meredith et al. 2013,  
Lombardo et al., 2009  
 2
ABSTRACT 
Current transgenic methodology developed for mosquitoes has not been applied widely to the major malaria 
vector Anopheles gambiae, which has proved more difficult to genetically manipulate than other mosquito 
species and dipteran insects. In this protocol, we describe phiC31-mediated site-specific integration of 
transgenes into the genome of An. gambiae. The phiC31 system has many advantages over “classical” 
transposon-mediated germ-line transformation systems because it allows integration of large transgenes at 
specific, characterised genomic locations. Starting from a general protocol, we have optimized steps from 
embryo collection to co-injection of transgene-containing plasmid and in vitro produced phiC31 integrase 
mRNA. We also provide hints for screening transgenic larvae. The outlined procedure provides robust 
transformation in An. gambiae, resulting in homozygous transgenic lines in approximately 2 to 3 months. 
 
INTRODUCTION 
Anopheles gambiae is among the most studied non-model organism for which molecular 
and genetic tools have been developed over the last two decades. This is due to its role as 
the main African vector of Plasmodium falciparum, the most deadly human malaria 
parasite.  
Since the establishment of the An. gambiae genome sequence in 2002 an abundance of 
proteomic, transcriptomic and genome wide association data have been produced to try to 
understand the intimate relationships between the mosquito and Plasmodium parasites with 
the aim of identifying rational new means to control malaria transmission 1-5. Other features 
of Anopheles biology relevant to disease transmission have also been intensively studied, 
including mating behaviour, sex determination, olfactory response and insecticide 
resistance 6-9.  
An. gambiae has previously been perceived as intractable for functional genetic studies, 
largely because of reduced transformation efficiencies compared to other mosquitoes and 
the more complex husbandry required to maintain colonies. To surmount this, several 
researchers have used Drosophila or Anopheles stephensi as a recipient species to analyse 
the function of An. gambiae genes 10-14 as these species are more robust and amenable to 
genetic transformation, and in the case of Drosophila, possess a complex genetic toolset. 
However, these heterologous systems have their limitations, since presumed orthologous 
genes may behave differently in An. stephensi, or in Drosophila, which is a non-blood 
feeding diptera 10,15. 
In parallel, transient RNAi was demonstrated as an alternative for functional analysis in An. 
gambiae 16. This methodology has proved successful for silencing gene expression in 
mosquito tissues encountered by Plasmodium parasites during its development in the 
mosquito 16-20. However, this method only permits loss-of-function studies, is labour 
intensive, and offers little selectivity over which tissues are targeted for knockdown. 
 
Transposon mediated germ-line transformation of An. gambiae 
Soon after the first report of successful transformation in An. stephensi 21 and the discovery 
that the piggyBac transposable element could mediate germ-line transformation in many 
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different insect species, Grossman et al.22 succeeded in producing An. gambiae transgenic 
mosquitoes. However, in contrast to several insect species, including mosquitoes such as 
Aedes aegypti, An. stephensi and Anopheles albimanus, transformation efficiency was much 
lower in An. gambiae and more technically challenging 22,23. Since then, several 
modifications to the protocol have improved the efficiency considerably, as outlined in Lobo 
et al.24. Technical details for producing transposon-mediated transgenic mosquitoes 
including An. gambiae have been published by several groups 24-27.  
The major attributes of transposon-mediated transformation are the inherent randomness 
of the integration site and the post-integration mobility of transposons allowing these 
approaches to be used for mutagenesis screens, including ‘classic’ exon and enhancer 
trapping strategies, as reported in An. stephensi by O’Brochta et al. 28,29. Transposons can 
be used to compare gene expression at multiple genomic sites 30. Conversely, these 
characteristics can be severe drawbacks for other types of functional genetic analysis. Non-
defined integration sites lead to position effect variegation and renders phenotypic 
comparison between transgenic lines difficult without the generation, characterization and 
maintenance of multiple independent homozygous lines 26,31. This initial characterisation 
can be extremely labour intensive involving the generation of multiple isoparental lines. The 
randomness also means that apparent phenotypic differences may relate to mutagenesis at 
the insertion site rather than transgene function, which complicates analysis. Furthermore, 
the generation of lines with multiple sites of transgene integration within a genome is 
common, which again hinders phenotypic studies 26. To overcome some of these problems, 
the phiC31 system has several characteristics that are advantageous for many functional 
genetic applications. 
 
Overview of the phi C31 system in An. gambiae 
The phiC31 system uses the properties of the site-specific integrase from the bacteriophage 
phiC31, which mediates recombination between an attachment site (attB) that is normally 
present in the genome of Streptomyces lividans, and an attachment site (attP) present in 
the circular genome of the bacteriophage phiC31. Recombination between the two att sites 
integrates the phage genome and forms two hybrid sites, attL and attR that are not targets 
for the phiC31 integrase, thus the integration event is irreversible32. 
To establish this system de novo in any organism, the first step is to integrate an attP site 
into the genome. In An gambiae, this was initially performed using attP tagged piggyBac 
transposons, that harbour a fluorescent marker gene under the control of the synthetic 
eye/nervous system-specific 3xP3 promoter, whose expression is easily visualised in 
mosquito larvae 33 (Figure 1 A). The resulting transgenic lines are called “docking strains”. 
The docking strains need to be characterised for homozygous fitness, to ensure line 
robustness, as well as the presence of single chromosomally integrated attP sites, to enable 
the production of phase two mosquitoes, described below, with integrase-mediated 
insertions at these unique, identical sites.  
The second step is to co-inject embryos from the docking strain with a transgene carried on 
a plasmid containing an attB site, and a source of the phiC31 integrase to promote site-
specific recombination in the germ cells of the injected embryos (Figure 1B). In most 
studies, in vitro produced mRNA is used as a source of integrase 33,34, but plasmid 
templates have recently also proved suitable (A. L., unpublished ; S. Fuchs, T. Nolan & A. 
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Crisanti, unpublished) in mosquitoes. From this second step, also named phase two, 
establishment of homozygous lines is straightforward as virtually all transgenics will have 
an identical transgene at the same location and therefore mass mating can be performed. 
This is critical for An. gambiae, a mosquito species that mates in swarms. Increases in 
transformation efficiency may also be derived from only using G0 larvae that transiently 
express the marker gene to establish subsequent crosses, as our experience indicates that 
these are more likely to generate transgenic offspring (E. P. & N. P., unpublished). 
 
Advantages of the phiC31-based transgenesis system in An. gambiae 
The phiC31-based transgenesis system offers several advantages over other systems, 
which should be considered when adopting this technology. These include i) integration of 
transgenes at specific, characterised genomic locations, ii) insertion of large constructs 
(larger than 42 kb, the size of the phage phiC31 genome), iii) irreversible integration of the 
transgene, iv) the predominance of single gene insertions and vi) potential increases in 
transformation efficiency (see details in Fish et al.35). Furthermore, it provides a simplified 
mating procedure to identify transformants, which should all be identical. This is a 
considerable benefit for An. gambiae that is not easily amenable to single pair mating. 
Overall, the ability to mitigate position effects on transgene expression is likely to be of 
principal importance for most applications, allowing for more efficient comparison between 
transgenic lines during phenotypic characterisation31.  
In D. melanogaster, the efficiency of phiC31-mediated transgenesis is reported to be 
approximately 5-fold higher than that mediated by P element transposase36. However, in 
mosquitoes extensive comparisons have not been described 31,33,37. The overall benefit of 
the development of the phiC31 system for producing transgenic An. gambiae has led to 
recent developments of novel tools in this mosquito including a synthetic homing 
endonuclease-based gene drive system 34 and the TALen system for targeted 
mutagenesis38. 
Further advances could be obtained by generating a minimal set of docking strains that 
bear an attP site on each of the three chromosomes of An. gambiae. These would need to 
be selected from a large batch of piggyBac-derived attP carrying transgenics, to optimise 
fitness and efficiency of site-directed modification. These tools would aid the development 
of efficient conditional expression systems, including Gal4/UAS in An. gambiae. In addition 
to gain-of-function studies, such a system would also permit functional analysis of alleles by 
a combination of stable RNAi and in vivo complementation to alleviate the otherwise 
laborious process of allele-specific transient RNAi18.  
One of the limitations of Anopheles transgenesis in general is the lack of a method for 
convenient line preservation, such as cold or dry storage. This means that lines may have 
to be reared continuously. Although efforts need to be focused on producing a suitable line 
preservation system, the relative efficiency of phiC31 transformation combined with the 
ability to create lines with insertions in identical sites means that it is feasible to re-
generate the lines de novo as required, rather than maintaining them for years. 
Experimental design 
Mosquito embryos Whatever the strategy chosen for producing transgenic An. gambiae 
mosquitoes, embryos will be exposed to stress at the time of injection from receiving 
exogenous nucleic acid material. Therefore, the quality of the embryos is paramount. 
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Beside specific care of the females from which embryos are collected, it is highly important 
to rear the larval juvenile stages to produce those mothers in optimal, healthy conditions. 
Particular care should be given to larval density and larval food access. Although not based 
on extensive testing, our experience leads us to highly recommend use of embryos 
produced from the first egg batch of young females. 
 
Designing AttB containing plasmids The standard docking strains currently available 
harbour the ECFP marker gene. Therefore a second fluorescent marker gene, usually YFP or 
DsRed, is necessary for efficient differentiation and selection of transgenics harbouring the 
transgene of interest. To be able to screen transgenics at all post embryonic stages, the 
most convenient regulatory region to drive the selectable marker gene is currently the 3xP3 
promoter, which yields expression in the eye and nervous system in mosquito larvae 
(Figure 2A). As the number of easily differentiated fluorescent proteins is not extensive the 
choice of markers needs to be carefully evaluated using published guides and based on the 
availability of suitable filter sets 39. Several plasmids with an attB site associated with 
different fluorescent proteins under the control of the 3xP3 promoter have been already 
constructed for phiC31 integrase-mediated transformation of Aedes and Anopheles 
mosquitoes and are available from the respective laboratories 33,37,40,41. Additional 
constructs developed for Drosophila might also be considered 42. 
PhiC31 integrase source To establish the procedure for the phiC31 integrase-based 
transformation system in Anopheles as well as in Aedes mosquitoes 31,37,40, Bombyx mori 43 
and Drosophila 35,36, in vitro transcribed mRNA was used as a source for phiC31 integrase. 
The use of mRNA is particularly suitable for non-model organisms, since it doesn’t rely on 
specific promoters to drive expression of integrase in the germ-line. However, since 
integrase mRNA is prone to degradation if precautions are not adhered to, this can lead to 
variability in transformation efficiency 35. An alternative way to provide the phiC31 
integrase is to co-inject helper plasmid, which is inherently more stable than mRNA. The 
recent successful use of the pKC40 helper plasmid44 in six independent experiments (A.L., 
unpublished) showed that this is efficient, although direct comparison of relative efficiency 
against mRNA has not been performed. The pKC40 plasmid carries the phiC31 integrase 
gene, with an additional carboxyl nuclear localization sequence, driven by the Drosophila 
hsp70 promoter. The recent development of additional helper plasmids driving integrase 
expression under germ-line specific promoters such as nanos or vasa (S. Fuchs, T. Nolan & 
A. Crisanti, unpublished) may also contribute to overall increased convenience of the 
system.  
Further sophistication of the An. gambiae system has been achieved 41 through the 
development of “self docking strains” that carry a genomic source of integrase similar to 
that described in Drosophila 42. In these strains the phiC31 integrase is expressed 
specifically in the germ-line, therefore only the attB plasmid containing the transgene needs 
to be injected into the embryos, resulting in an increased survival rate up to 60%. This 
system has proved to be efficient 41, and although phase 2 integrations are stable, two 
options exist for the subsequent removal of integrase expression. Firstly, the integrase and 
fluorescent marker genes in the self-docking strains were designed to be excised using Cre-
loxP following site-specific integration (J.M.M. & P.E., unpublished). Secondly, since the 
fluorescent marker is different in the self-docking strains (Figure 2B), these can be used as 
integrase ‘driver’ line, to provide integrase in trans, following a cross to an existing 
characterised differently marked standard docking strain. In the embryos derived from 
these crosses only the attB plasmid needs to be injected, and screening of a G0 outcross to 
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wild type will detect those transgenics only carrying the donor plasmid and not the 
integrase marker. 
Here, we describe the step-by-step procedure for efficient site-specific transformation of 
An. gambiae using established docking strains. An outline is provided in Figure 3. The 
protocol includes the preparation of the embryos for injection, the in vitro synthesis of 
integrase encoding mRNA and the selection of transgenic mosquitoes up to the 
establishment of homozygous lines. We have emphasised the procedure for in vitro 
production of mRNA encoding integrase and the associated care as this procedure will likely 
be the entry point for phiC31-mediated transgenesis in other mosquito or insect species 
lacking refined molecular tools, such as a characterized promoter to drive efficient phiC31 
integrase expression. In addition, we have included a video to document the delicate initial 
step of embryo alignment. 
 
MATERIALS 
REAGENTS:  
• Anopheles gambiae attP docking strains or self-docking strains (see Table 1 for available 
strains) 
• phiC31 integrase-containing plasmid (see REAGENT SETUP) 
• Transgene-containing plasmid (see REAGENT SETUP) 
• LB broth (cat. no.12780-052, Invitrogen) 
• Ampicillin (cat. no. A9518-5G, Sigma Aldrich)  
• RNAse away spray (cat. no. 7002, Molecular BioProducts) 
• EndoFree Maxiprep purification kit (cat. no. 12362, Qiagen) 
• Genomic DNA extraction kit (RedExtract-N-Amp™ Tissue PCR Kit, cat. no. X-NAT-
1KT, Sigma) 
• Ultrapure Agarose (cat. no. 16500-500 , Invitrogen) 
• 50X TAE buffer (cat. no. 24710-030 , Invitrogen)  
• Ethidium bromide (cat. no. GEPBET02-AF, EUROBIO) ! CAUTION Ethidium bromide 
is a mutagen. Wear a lab coat and protective gloves.  
• 1Kb ladder (cat. no. N3232S, NEB)  
• ssRNA ladder (cat. no. N0362S, NEB) 
• BamHI Restriction enzyme (BamHI HF, cat. no. R3136S, NEB) 
• Nuclease-free water (cat. no. 9932, Ambion) 
• Ethanol 100% (absolute for analysis) 
• 3M Sodium Acetate pH 5.5 (cat. no. 9740, Ambion) 
• 0.5 M EDTA pH 8.0 (cat. no. 9269G, Ambion) 
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• In vitro RNA transcription kit (mMessage mMachine T7 ULTRA, cat. no. 1345, Ambion) 
• RNA purification kit (MEGAclear kit, cat. no. 1908, Ambion) 
• 0.22 µm-filtered 25 mM NaCl  
• Halocarbon Oil 700 and 27 (cat.no H8898 & H8773, Sigma-Aldrich) 
• microinjection buffer pH 7.2 (see REAGENT SETUP) 
• Artificial sea salts (0.3 g/L, see MR4 Methods in Anopheles research, 
http://www.mr4.org/Publications/MethodsinAnophelesResearch.aspx) 
• Tetramin baby fish food (Tetra) 
• Deionized sterilized water for G0 embryo hatching 
• 10% sucrose solution (any commercial food sugar supplier) 
 
EQUIPMENT 
• Laboratory gloves (eg. cat. no. XC-INT-M, Microflex) 
• Double-sided sticky tape (cat. no. 415, 3M) 
• 18 mm X 18 mm glass coverslips (eg. cat. no. BB018018A1, Thermo Scientific Menzel) 
• Glass slides (eg. cat. no. AG00000112E01, Thermo Scientific Menzel) 
• Fine forceps (N°5, Dumont) 
• Fine paintbrush N°2/0 (1.3 mm) (eg. cat. no. 8400, Raphael) 
• Whatman Filter papers for embryo alignment (cat. no. 1450-090, Whatman) 
• Microinjection needles: Quartz micropipettes with filament (OD: 1.0 mm, ID: 0.70 mm) 
(cat. no. QF-107010, Sutter instrument) or Alumino-silicate glass capillaries with filament 
(OD 1.0mm, ID 0.64 mm) (cat. no. AF100-64-10, Intracel, Herts, UK) (see EQUIPMENT 
SETUP)  
• Microloader pipette tips (cat. no. 5242956003, Eppendorf) 
• Modeling clay  
• Plastic Petri dish (diameter 90 mm ; for storing pulled needles and for G1 screening) 
• Filter paper 100% cellulose for G1 screening (thickness 0,13 mm, filtration speed 50 sec, 
weight 64 g/m², retention 10-20 μm, any brand or Fiorioni- http://www.filtres-
fioroni.com/) 
• Transfert pipettes (cat. no. 225-1S, Samco Scientific) 
• Microscope slides with wells (eg cat. no. 101432648EPOXY, Thermo Fisher) 
• Natural Dry Cellulose Sponge N°4 (cat. no. 95030072, Spontex) 
• 2L Popcorn boxes  
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• Hygienic Dental Dam Latex" (cat. no. H02146, Coltene/Whaledent) 
• RNase free microfuge tubes 1.5 ml (cat. no. 12400, Ambion) 
• 0.22 µm Microfilters (Ultrafree-MC sterile, cat. no. UFC30GVOS, Millipore) 
• 50 ml Polypropylene Tubes (cat. no. 352098, Corning) 
• Insectaries (26°C, 80% relative humidity, 12:12h light photoperiodicity) 
• Black box or insectary with inverted day/night photoperiod 
• Standard mosquito rearing material (see MR4 Methods in Anopheles research; 
http://www.mr4.org/Publications/MethodsinAnophelesResearch.aspx) 
• Needle puller (Sutter P-2000, Sutter Instruments) 
• Inverted microscope (eg. TS100 Eclipse, Nikon) 
• Femtojet microinjector (Femtojet Express, Eppendorf) 
• Joystick Micromanipulator (eg. Leica or MN-151 Narishige) 
• Fluorescence stereomicroscope or macroscope (eg. AZ100, Nikon) with appropriate filter 
sets 
• UV light to visualize gels (eg. Chemidoc, BioRad)  
• Spectrophotometer (eg. ND-1000, Nanodrop) 
• Oviposition chambers, custom-built (see EQUIPMENT SETUP)  
 
REAGENT SETUP 
Embryo harvesting Rear mosquitoes according to standard protocols with an adequate larval 
density:food ratio to obtain large and healthy mosquitoes that will emerge synchronously 
(MR4 standard protocol 
http://www.mr4.org/Publications/MethodsinAnophelesResearch.aspx). Approximately seven 
days before injection, prepare a large cage (30 x 30 x 30 cm) with freshly emerged adults 
(about 200 females and 100 males) and provide sugar (10% sucrose) ad libidum. Four days 
post emergence, ensure efficient blood feeding of females. Females will be able to lay suitable 
eggs on the 3rd and 4th days post-feeding. For embryo collection, place a small amount of 
deionized water in the cap of an oviposition chamber (see EQUIPMENT SETUP), place 
chamber on cap and introduce about 10 females through the dam (Figure 4). Place the 
chamber in the dark to allow females to lay eggs over a 20 minute period. Set up two 
oviposition chambers to ensure enough eggs for each injection series. Females are then 
removed and eggs left in the tube cap for 30 min in the insectary until they begin to melanize 
to light grey. At that stage they are suitable for alignment and injection 24,25 and are 
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transferred to the injection room conditioned at 18-20°C to slow down embryo development. 
Such embryos should be injected within 2 hours of laying to ensure optimal development of 
the embryos. After this time, chorion hardening may render the eggs difficult to inject. Under 
optimal rearing conditions, at least 250 eggs can be recovered from each chamber.  
CRITICAL Females need to be inseminated for egg laying. If females do not lay eggs, control 
that females are inseminated by dissecting their spermathecae. 
 
PhiC31 integrase-containing plasmid For in vitro transcription of mRNAs encoding phiC31 
integrase, a plasmid containing the phiC31 integrase gene coupled with a RNA polymerase 
promoter is required. We use the original pET11phiC31poly(A) 35,36 provided by Pr Calos. 
Other transcription plasmids containing mutated and insect codon-optimized phiC31 integrase 
have been designed with the aim to increase transformation efficiency but such improvements 
have not been observed in A. aegypti or An. stephensi 14,31. 
Transgene-containing plasmid The transgene has to be cloned into a recipient plasmid 
containing an attB attachment site plus a screening marker distinguishable from the one 
present in the docking strain. Several plasmids with an attB site associated with different 
fluorescent proteins under control of the 3xP3 promoter have been already constructed for 
phiC31 transformation of Aedes and Anopheles mosquitoes and are available from the 
respective laboratories 37,40,41. Information on the phiC31 phage sequence can be found at the 
accession number AJ006589 and information on the 3xP3s synthetic promoter at the 
GeneBanK accession number AB779767.1 and at 
http://flybase.org/reports/FBtp0017474.html. 
1X microinjection buffer pH 7.2 Add 0.1 ml of sodium phosphate buffer 0.1 M pH 7.2 and 
1 ml of KCl 0.5 M to deionised water. Adjust volume to 100 ml. Filter-sterilize (0.22 µm), 
aliquot in small volumes and store at 4°C or -20°C.  
Water-saturated Halocarbon oil Mix 9 ml Halocarbon Oil 700, 1 ml Halocarbon Oil 27 and 
10 ml molecular biology grade water gently to avoid forming an emulsion. Leave to stand at 
room temperature (20°C-22°C) overnight to allow the Halocarbon oil to become water 
saturated.  
 
EQUIPMENT SETUP 
Oviposition Chambers Cut the bottom of 50 ml polypropylene tubes and cover this opening 
with a piece of dental dam latex. Make a small cut in the membrane to introduce mosquitoes. 
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A piece of lab latex glove is an alternative. Add deionized water to the cap of the 
polypropylene tube to serve as the oviposition site (Figure 4). 
Pulling Needles for Microinjection We have used both quartz and alumino-silicate glass 
needles. Pull quartz needles using the following parameters on a Sutter P-2000: HEAT 750, 
FIL 4, VEL 40, DEL 150, PUL 165, which are similar to those described in Lobo et al.24. Pull 
alumino-silicate needles using the following parameters: HEAT 430, FIL 120, VEL 50, DEL 
210, PUL 250. Parameters may need to be adjusted slightly depending on the accuracy of the 
alignment of individual P-2000 pullers and variation in needle batches. It is useful to pull a 
large number of needles to replace ones that break or get clogged during injections (usually 
about 5 needles per 150 embryos). Pulled needles are stored on modeling clay in a closed 
Petri dish at room temperature (RT: 20-22°C) until use. The tip of the needles is sealed during 
pulling but will usually open sufficiently when attempting to inject the first embryo. 
! CRITICAL Although quartz micropipettes are more expensive than alumino-silicate glass 
needles and require the higher temperature of a laser puller, they perform better. Some 
researchers have also been successful in using commercial Femtotips27. Quartz needles are 
more resistant than other glass needles to damage often caused during the penetration of the 
hard embryo chorion. The presence of filaments increases flow, which aids the filling of the 
injection needle and solution flow while injecting. 
! CRITICAL Wear gloves when pulling needles to avoid degradation of mRNA whilst 
injecting embryos if using mRNA as a source of integrase. 
! CRITICAL If the needle shape after pulling is not reproducible; check first the quality of the 
needle batch. If the puller is not reproducible, refer to the puller set up instructions. It is 
critical to use and maintain the needle puller correctly to obtain pulled needles of reproducible 
quality. 
Filling needles Back fill needles using 3-5 μl of plasmid or plasmid/mRNA mix using 
Microloader pipette tips (Eppendorf). 
Injection slides and embryo alignment coverslips Tape two coverslips on a glass slide 1 cm 
apart. Place on the edge of each coverslip a piece of double-sided sticky tape, which will later 
receive the coverslip with aligned embryos. Prepare coverslips for collecting aligned embryos 
by placing one piece of double-sided sticky tape on each. Prepare an excess of small squares 
of filter paper with sharp scissors to minimize fibers (see Supplementary video 1). Injection 
slides and coverslips can be prepared in advance and stored in a dust-free environment.  
Screening methods and fluorescence microscopy Screening of fluorescent larvae can be 
done with most fluorescence microscopes with appropriate filter sets to distinguish between 
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the different fluorescent markers 39,45. For ECFP, a 421/456nm activation - 461/504nm 
emission filter set and for dsRed a 538/588nm activation - 600/652nm emission filter set can 
be used. We favour the use of a stereomicroscope or AZ100 Nikon macroscope, due to the 
convenience of handling specimens. There are multiple methods available to screen G1 larvae 
on mass, which all rely on reducing mobility of the larvae whilst keeping them moist, either 
by chilling or filtering, so that they can be viewed under a stereoscope and fluorescent 
transformants easily recovered. One simple method that can be used involves filtering on 
cellulose discs and preservation on damp sponges during manipulation. For this method, 
prepare 90 cm disks of 100% cellulose filter papers to fit into Petri dishes. Draw lines 0.5 cm 
apart to screen larvae by row (Figure 5). This will facilitate orientation under the microscope 
and enable the complete screening of large batches of larvae. 
 
PROCEDURE 
! CRITICAL Steps 1-31 & 38-39 (i.e. up to embryo injection) have to be carried in an RNAse 
free environment when injecting standard docking strains with mRNA encoding the phiC31 
integrase, to avoid RNA degradation. Clean the bench and pipettes with an RNAse away 
spray. Always wear gloves during preparation of mRNA, from establishing the culture to the 
final mix preparation. Use RNAse free microfuge tubes. 
CRITICAL It is best to make fresh (less than 10 days) preparations of DNA and mRNA. We 
used to make the injection mix the week before injections. For long-term storage, store 
nucleic acid preparations in RNAse free 70% ethanol.  
CRITICAL We recommend verifying the quality and identity of the plasmid to be injected at 
the relevant steps, as the whole process to obtain transgenic is 2 to 3 months. 
 
Preparation of plasmid DNA carrying the transgene TIMING 3 days 
1. Once the DNA of interest is cloned in an attB-recipient vector and its sequence 
verified, make a fresh transformation of the plasmid using standard protocols.  
! CRITICAL STEP To obtain a good yield, it is necessary to make a culture from a 
freshly transformed clone.  
! CRITICAL STEP We recommend using SURE2 cells (Stratagene) to avoid recombination 
during bacterial growth.  
CRITICAL STEP If using mRNA as a source of integrase, step 9 can be carried out in 
parallel to step 1-4. 
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2. The next day, grow a single colony in 1 ml of LB supplemented with 100 µg/ml 
ampicillin for 8 hours at 220 rpm 37°C with aeration.  
3. Transfer 100 µl to a 1 liter flask containing 100 ml LB and 100 µg/ml ampicillin and 
grow overnight at 240 rpm 37°C with aeration. 
4. Extract plasmid DNA with an endotoxin free purification kit according to the 
manufacturer’s instructions. Elute DNA with 500 µl of pre-warmed nuclease-free 
water. Measure DNA concentration (250 to 500 µg should be recovered). Confirm 
identity of the plasmid by restriction enzyme digest.  
5. Precipitate plasmid DNA with 0.1 volumes 3M sodium acetate and 2.5 volumes of 
100% ethanol, 30 min at -20°C.  
CRITICAL STEP It is possible to aliquot DNA into smaller quantities before ethanol 
precipitation to avoid potential DNA degradation upon repetitive freezing and 
thawing. 
6. Centrifuge at 15,000g for 15 min at 4°C.  
7. Wash the DNA with 1 ml of 70% ethanol (100% ethanol diluted in nuclease-free 
water).  
PAUSE POINT Plasmid DNA can be stored in 70% ethanol at -20°C until use.  
8. (OPTIONAL) If using self-docking strains follow Option A, if using helper integrase 
plasmid follow Option B. Otherwise, proceed directly to step 9 to prepare integrase 
mRNA. 
Option A: Self-docking strains 
i. Centrifuge attB plasmid DNA from step 7 at 15,000g for 5 min, 4°C.  
ii. Air-dry the DNA pellet for 5 min and resuspend at about 300 ng/µl in 1X 
injection buffer.  
iii. Measure the DNA concentration to ensure no DNA has been lost during the 
precipitation. Check also the DNA purity by measuring OD 260/280, which 
should not be less than 1.8. 
iv. Spin again at 15,000g for 5 min to remove any particulates. The DNA is now 
ready for injection at step 39. 
Option B: Helper plasmid. 
i. Centrifuge attB plasmid DNA from step 7 at 15,000g for 5 min, 4°C. Air-dry 
the DNA pellet for 5 min and resuspend at about 1 µg/µl in nuclease-free 
water. 
ii. Mix plasmids at a ratio of 7:3  attB plasmid:helper plasmid. 
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iii. Precipitate DNA as described in steps 5-7. 
iv. Centrifuge DNA mix at 15,000g for 5 min, 4°C. 
v. Air-dry the DNA pellet for 5 min and resuspend the DNA mix in 1X injection 
buffer at a final concentration of 500 ng/µl. 
vi. Measure the DNA concentration to ensure no DNA has been lost during the 
precipitation. Check also the DNA purity by measuring OD 260/280, which 
should not be less than 1.8. 
vii. Spin again at 15,000g for 5 min to remove any particulates. The DNA is now 
ready for injection at step 39. 
 
mRNA phiC31 integrase synthesis TIMING 4-6 days 
9. Transform pET11-PhiC31polyA integrase-containing plasmid, establish cultures, 
extract plasmid DNA and confirm plasmid identity as described in steps 1-4. 
 PAUSE POINT The DNA can be stored at -20°C until required.  
10. Linearize 40 µg of pET11-PhiC31polyA plasmid with BamHI HF at 37°C overnight 
as recommended by the manufacturer but using RNASE-free water as a diluent.  
11. Next morning, check for digestion completion by running an aliquot (500 ng) on a 1% 
agarose gel in 1X TAE buffer; a unique band at 8kb is expected. 
12. Stop the digestion and precipitate the digested plasmid by adding 1/20 volume 0.5 M 
EDTA, 1/10 volume 3M Sodium Acetate and 2 volumes of 100% ethanol. Leave 30 
min at -20°C.  
13. Centrifuge at 15,000g 15 min, 4°C.  
14. Rinse the pellet with 1 ml of 70% ethanol (100% diluted in RNAse-free water).  
15. Centrifuge at 15,000g, 5 min, 4°C. 
16.  Remove the supernatant and air-dry the DNA pellet before addition of 40 µl of 
RNAse-free water. Verify that DNA concentration is around 1 µg/µl using a 
NanoDrop and run an aliquot of the purified linear template on an agarose gel for 
quality control. 
PAUSE POINT The linear DNA can be stored at -20°C until required.  
17. Perform in vitro phiC31 integrase mRNA synthesis using the T7 ULTRA mMessage 
mMachine kit following the manufacturer’s instructions. To inject approximately 2000 
embryos, about 250 µg of mRNA is required. This amount can be obtained from 4 
reaction tubes, each using 1 µg of the digested T7 phiC31 integrase DNA template 
from step 16. Incubate at 37°C for at least 4 hours (can safely be left overnight).  
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18. (OPTIONAL) Remove the DNA template using TURBO DNAse (included in the in 
vitro mRNA synthesis kit) and add a poly(A) tail to the mRNA according to the 
manufacturer’s instructions. Although inclusion of this step adds to the overall time, it 
results in higher purity and stability of the mRNA and might increase the number of 
site-specific integration events.  
CRITICAL STEP Remove 2.5 µl per RNA sample before adding the poly(A) 
polymerase and keep on ice; this control will be run on a gel next to the tailed mRNA after 
mRNA purification at step 20.  
CRITICAL STEP Always keep the mRNA on ice and proceed directly to purification 
(step 19).  
19. Purify the mRNA using the MEGAclear kit following the manufacturer’s instructions. 
Use one column per two mRNA reactions. Elute each column with 2x50 µl of 
supplied elution solution prewarmed at 95°C. Pool the 200 µl eluted mRNA and keep 
on ice.  
20. Measure mRNA concentration (200 to 260 µg should be recovered). Verify mRNA 
quality on an agarose gel run at 50V; before loading, denature 2.5 µl of mRNA 
(untailed mRNA from step 18 and tailed one) and 3 µl of ssRNA ladder in ssRNA 
buffer following manufacturer’s instructions. The untailed phiC31 integrase mRNA 
should be 1840 bp while the tailed one, if step 18 was performed, should be over 2000 
bp. 
21. Precipitate the mRNA with 5M ammonium acetate supplied in the MEGAclear kit 
following manufacturer’s instructions.  
PAUSE POINT mRNA can be stored when in 70% ethanol (100% ethanol diluted in 
nuclease-free water) at -20°C. After this step, there is no other pause point until storage of the 
injection mix at step 31.  
22. Recover the precipitated mRNA by centrifugation, 15,000g for 15 min, 4°C, rinse with 
RNAse-free 70% ethanol. Resuspend the air-dried pellet in 200 µl of nuclease-free 
water prewarmed at 65°C and keep the tube on ice. 
! CRITICAL STEP Do not air dry the pellet too much as it will be difficult to 
resuspend.  
23. Determine mRNA concentration to verify full recovery of mRNA after precipitation. 
Check the mRNA purity by measuring the OD 260/280, which should be about 2.0. 
Proceed directly to injection mix preparation. 
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Preparation of DNA-mRNA mix for injection TIMING 1 to 2 days 
24. Centrifuge plasmid DNA from step 7 at 15,000g for 5 min, 4°C.  
25. Air-dry the DNA pellet for 5 min and resuspend at about 1 µg/µl in nuclease-free 
water.  
26. Measure the DNA concentration to ensure no DNA has been lost during the 
precipitation. Check also the DNA purity by measuring OD 260/280, which should not 
be less than 1.8. 
27. According to the concentration of the purified plasmid DNA (from step 26), add an 
adequate volume of plasmid DNA to the purified mRNA to recover the recommended 
concentration after co-precipitation in 1X injection buffer. Plasmid DNA is injected at 
250 ng/µl (if plasmids are under 12 kb) and mRNA encoding phiC31 integrase at 800 
to 1000 ng/µl. 
 ! CRITICAL STEP When using larger plasmids, we observed a decrease in transformation 
efficiency. To increase efficiency, increase DNA concentration up to 350 ng/µl. However, 
high concentrations can clog needles. This can be limited by a larger needle tip; however, a 
larger tip will result in a decrease in embryo survival 24. 
28. Precipitate the DNA-mRNA mix with 5M Ammonium Acetate (supplied in the 
MEGAclear kit) following manufacturer’s instructions. After the 70% ethanol wash 
and centrifugation, resuspend the air dried pellet in 1X injection buffer prewarmed at 
65°C and keep the tube on ice. 
! CRITICAL STEP Do not air dry the pellet too much as it would be difficult to resuspend.  
29. Filter the mix with a 0.22 µm microfilter at 13,000 g for 5 min at 4°C.  
30. Verify injection mix quality on an 1% agarose gel run at 50V, running side by side: 3 
µl of denatured filtered injection mix, 500 ng of plasmid DNA preparation from step 
26 and 3 µl of ssRNA ladder in ssRNA ladder buffer. The plasmid DNA should 
present 2 bands corresponding to different types of circular DNA structure and the 
mRNA should be over 2 kb.  
31. Aliquot 15 µl samples of the injection mix and store on ice. Small aliquots are 
recommended as mRNA production is expensive and mRNA sensitive to degradation.  
PAUSE POINT Store aliquots at -80°C until embryo injections. The mix should not be 
refrozen once thawed. 
 
Embryo alignment for microinjection TIMING 10-20min/ batch of 50 embryos 
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CRITICAL: Methods for aligning Anopheles eggs have been well described 24-27,46. Our 
procedure is very similar to those described in 24,26. As the method is intricate, we provide a 
video (See Supplementary video 1).  
CRITICAL For alignment and injections, condition the room at 18-20°C to slow down 
embryo development.  
32. Place a small square of filter paper on a glass slide and add a drop of 25 mM NaCl to 
moisten the paper, leaving a fine line of buffer around the edges. Ensure no air bubbles 
are trapped between the paper and the glass slide.  
33. Deposit a drop of 25 mM NaCl on the glass slide near to the edge of the filter paper.  
34. With a fine paintbrush, transfer about 50 embryos into the drop of NaCl. Align 
embryos against the filter paper- which should be wet enough to ensure the embryos 
are in contact with the solution, but not so wet that it attracts them. Align 30 to 50 
eggs with the anterior pole (the larger one) against the paper and with the dorsal side 
(flattened one) facing up. 
! CRITICAL STEP Do not let the embryos become dry. If needed, add drops of 25 mM NaCl 
to the paper to maintain moisture as required.  
35. Once embryos are aligned, absorb the solution from the wet filter gently but quickly 
with fresh filter paper. This will allow the embryos to partially desiccate.  
36. Remove the alignment filter paper gently and apply the coverslip to glue the embryos 
to the tape. Turn over the coverslip and immediately cover embryos with a drop of 25 
mM NaCl or Halocarbon oil.  
CRITICAL STEP Both 25 mM NaCl or Halocarbon oil have been used successfully for An. 
gambiae transformation 33,47. Use of Halocarbon oil has the advantage of improved visibility 
of both the embryos and needle tip, and increases the delimitation of the periplasm space and 
yolk in the embryos. However, its use requires an additional step of oil removal to ensure high 
survival rate of the injected embryos. 
37. Position the coverslip on the injection slide (see EQUIPMENT SETUP), and transfer 
it to the microscope stage for injection. To inject a large number of eggs, it is 
convenient to work in team of two persons, one aligning and one injecting. This way, 
it is possible to inject continuously. 
CRITICAL STEP The quality of eggs is of great importance for transformation success. We 
select embryos on several criteria as described by Lobo et al. 24 to maximize survival after 
injection. White or yellowish eggs, eggs that are too dark, small or thin eggs, and those with 
visible defects in the chorion or in their morphology, are discarded. Moreover, we try to align 
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eggs that are at a similar melanization stage, which facilitates injecting as they will have 
similar chorion hardness. The level of desiccation is also critical. Under-desiccated embryos 
will expel yolk after the injection needle is removed and are likely to die ; over-desiccated 
embryos will be soft and difficult to inject and are more likely to sustain serious damage. A 
set of aligned un-injected embryos can be used as a quality control for hatching rate, which 
should be of 95-100% leading to adult emergence rate of about 80% in optimal conditions.  
 
Embryo microinjection TIMING 4 to 8 days  
CRITICAL Injections are carried out at a 200X magnification as previously described 24,25. 
38. Thaw an aliquot of the injection mix on ice. If injecting a self-docking strain, use the 
injection mix from step 8A. If using a helper plasmid as the source of integrase, use 
the injection mix from step 8B. If using mRNA as an integrase source, use the 
injection mix from step 31. 
39. Fill a pulled needle (see EQUIPMENT SETUP) with 3 to 5 µl of injection mix and mount 
it on the micromanipulator.  
40. Focus on the embryo floats and gently position the needle until it is visible in the same 
optical field. The angle of the needle from the horizontal coverslip plane should be 
between 15 and 30 degrees.  
41. Set up the parameters of the Femtojet Express (constant pressure Pc and injection pressure 
Pi). They should be adjusted depending on the capillary size, the embryo batch and the 
state of maturation and desiccation. Generally, Pc is around 1000 HPa and Pi varies 
between 2000-3000 HPa. If injecting under Halocarbon oil, the droplet size can be 
monitored between injections by injecting into the oil and adjusting the FemtoJet 
parameters to give the required droplet size. If the needle is very thin and properly broken, 
injections can be made by using the CLEAN function, and no resistance should be felt 
during chorion penetration.  
42. Inject embryos on their ventral side, which faces up, at the posterior pole (the thinner 
one), between the posterior of the floats and the posterior pole of the embryo. Inject as 
much mix as the embryo can support without inflicting damage. Inject as many eggs as 
required. 
! CRITICAL STEP Do not inject in the terminal end of the posterior pole as it is harder and 
more difficult to penetrate with a needle. A useful drawing can be found in Lobo et al. 24. 
Depending on manipulator preference, injection can be performed either by moving the 
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microscope plate or by moving the needle using the joy stick of the micromanipulator. The tip 
of the needle should open on first contact with an embryo.  
CRITICAL STEP To prevent clogging and to check that the needle isn’t clogged, use the 
CLEAN function between each injected embryo. Change needles that cause excessive embryo 
damage. An embryo that continues to lose yolk material from the wound site will not survive. 
TROUBLESHOOTING 
43. Submerge the coverslip supporting injected embryos in a dish with about 1 cm of 
deionized-sterilized water supplemented with artificial sea salts. If injecting under 
Halocarbon oil, position the coverslip vertically to allow the oil to flow away from the 
eggs.  
! CRITICAL STEP Do not add food until larvae hatch to avoid microbial development that 
might impair embryo recovery from injection.  
44. Discard the remaining thawed injection mix at the end of the injection day. Transfer 
the vessels containing the injected eggs to insectary conditions until larvae hatching 
(48h to 72h post-injection). 
CRITICAL STEP Using this protocol, a hatching rate of 25-50% can be obtained 
using the standard docking strains and up to 60% with the self-docking strains, in 
which less amount of nucleic acid are injected. 
 
Rearing injected embryos to 3rd or 4th instar larvae TIMING 8 to 9 days 
45. Collect newly hatched larvae daily and transfer them to fresh rearing trays with clean 
water supplemented with salts. Ensure larvae of the same developmental stage are 
placed in the trays. 
TROUBLESHOOTING 
46. Carefully control larval density and food as larval health has a strong impact on adult 
size and fecundity (MR4, chapter 2). Feed larvae with Tetramin baby fish food from 
the 1st to 2nd instar. Then, rear larvae as recommended in MR4 standard protocols 
(MR4, chapter 2.4.4) up to the 4th instar. In optimal conditions, no or very few larvae 
will die between the 1st and the 4th instar.  
 
Screening transient fluorescence in generation 0 (G0) larvae TIMING 1 day 
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CRITICAL A good indicator for successful transformation is the presence of G0 larvae with 
transient fluorescence due to episomal presence of injected DNA plasmid. Transient 
fluorescence can be observed in the posterior region of larvae (Figure 6). From recent 
experiments we observed that more transformants are recovered from progeny of G0 larvae 
expressing transient fluorescence than from progeny of G0 larvae that do not (E.P.& N.P., 
unpublished). Therefore breeding only from G0 larvae expressing transient fluorescence can 
save time and space for G1 production, rearing and screening. 
47. Screen transient fluorescent G0 larvae by placing individual larvae in wells of an 8 
well glass slide, and observe fluorescence under the stereomicroscope. Minimize the 
amount of water in each well without drying the larvae, to facilitate rapid screening. 
Following this protocol, transient fluorescence can be observed in about 30 to 50% of 
larvae depending on injection series.  
TROUBLESHOOTING 
48. Transfer larvae expressing transient fluorescence to the rearing tray with their 
previous rearing water and rear them until pupation which will occur over the two 
following days.  
 
Crosses of G0 adults and rearing progeny (generation 1, G1) TIMING 1 month  
49. When G0 adults emerge, collect males and females daily and place in two separate 
cages. Collecting newly emerged mosquitoes daily ensures that females remain virgin. 
Alternatively, sexing and separation can be performed at the pupal stage. In parallel, 
collect virgin males and females from the docking strain of the same age as the G0 
adults.  
50. Set up backcrosses of G0 males to virgin females from the docking strain 3 to 5 days 
after emergence, when males are sexually mature. Make pools of 10 G0 males plus 50 
virgin females from the docking strain to optimize mating opportunities of each male. 
Allow at least 4 days for mating and then combine all G0 males and their 
corresponding mated females in a large cage.  
CRITICAL STEP To minimize space needed for cages, it can be convenient to use 
disposable 2 liter popcorn containers. The wild-type strain, rather than the docking 
strain, can be used for outcrossing if required to increase genetic diversity. 
CRITICAL STEP As An. gambiae mosquitoes need large amounts of space to mate, use cages 
or boxes with a minimum volume of 2 liters for crosses as this will ensure a minimum of 75% 
mated females in 4 days. 
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51. Collect G0 females over a week and place them all together in a large cage (30 x 30 x 
30 cm) and backcross to a 5-fold excess of mature virgin males (older than 3 days) 
from the docking strain. 
CRITICAL STEP As An. gambiae mosquitoes need large amounts of space to mate, use cages 
or boxes with a minimum volume of 2 liters for crosses as this will ensure a minimum of 75% 
mated females in 4 days. 
52. Blood-feed females from each cross (G0 males x docking females; G0 females x 
docking males) 4 to 5 days after having established crosses. 
53. Harvest the first batch of eggs and provide a second and even a third blood-meal and 
collect eggs after each blood-meal to obtain additional progenies. In our experience, 
we have not observed transgenics in the 3rd batch, if none were present in the first two 
batches. However, under normal conditions, where transformants are observed in the 
first two batches, a 3rd batch allows more G1 positive larvae to be collected, helping 
with transgenic line establishment.  
54. Control the G1 larval density and food quantities carefully to maximize larval survival 
as described in step 46.  
Screening G1 transgenic larvae TIMING 4 to 6 days  
55. Collect 200 to 300 larvae, preferably L3-L4 stages, and place them on an 8 cm 
diameter circular cellulose paper on top of a moist sponge (Figure 5). Let the sponge 
absorb enough water that larvae do not move whilst keeping enough moisture to 
preserve the larvae.  
CRITICAL STEP Remove food from the water before pipetting larvae otherwise it 
will result in autofluorescence background during the screen. 
 
56. Transfer the filter paper containing the larvae to a Petri dish under the fluorescence of 
a stereomicroscope to select transgenic larvae.  
! CRITICAL STEP We frequently observe G1 larvae with fluorescence restricted to one eye 
or both eyes and that showed no expression in the anal papillae as expected from expression 
driven by the 3xP3 promoter (Figure 7). They are presumably false positive transgenic G1, as 
no stable transgenic progeny have been obtained from these larvae (E. P. & N. P., 
unpublished). Nevertheless, we noticed that presence of such larvae is correlated with finding 
genuine transgenic larvae in the same G1 batch. In addition, we observed this type of larvae 
only in G0 female progeny (E. P. & N. P., unpublished), suggesting that the false positive 
 21
signal might be generated from the injected DNA plasmid maintained as an episome from the 
injected embryo over one generation.  
TROUBLESHOOTING 
57. Carefully transfer transgenic G1 larvae with a fine paintbrush back to small trays filled 
with their previous rearing water. Add a small amount of food and rear normally until 
adult emergence. 
Establishment of homozygous transgenic lines TIMING 2 months 
58. At G1 adult emergence, separate males and females into two different cages and 
backcross them when sexually mature utilizing a 20-fold excess of the opposite sex 
from the docking strain.  
59. Blood-feed the cages two or three times to maximize the numbers of transgenic 
mosquitoes obtained. In the G2 generation, select only fluorescent larvae, which 
should represent 50% of total larvae. 
60. From a subset of fluorescent larvae extract genomic DNA using standard methods47 
and confirm by PCR the presence of the canonical phiC31 recombination sequences 
attL and attR (see Table S1 for primers and PCR parameters) and the presence of 
transgene (using transgene-specific primers). At this stage, fluorescent larvae are 
heterozygous and should be positive for attP, attL and attR. It is advisable to verify the 
integrity of the transgene by PCR cloning and sequencing. 
61. Intercross G2 positive heterozygous mosquitoes and blood-feed them.  
62. Select G3 homozygous larvae on the basis of higher fluorescence intensity than that of 
heterozygous larvae. At this stage, about 25% of larvae should be homozygous for the 
integrated transgene if it has no harmful effect. 
 ! CRITICAL STEP Keep an amplified back-up of the heterozygous transgenic mosquitoes 
until establishment of the homozygous line. Moreover, try to keep at least two independent 
pools derived from the transgenic G1 mosquitoes (progeny from G0 males and G0 females for 
example). PhiC31 integrase is a site-specific transformation system and in our experience 
with An. gambiae, we have not yet observed non-specific integration. However, insertions 
into pseudo-attP sites cannot be excluded as they are documented in mammalian and 
Drosophila cells as well as in the mosquito A. aegypti 36,40,48. Maintaining two independent 
heterozygous lines should ensure that one of the lines contains the insert at the expected site. 
63. Extract DNA from the leg of each G3 mosquito to be used for intercrossing using the 
RedExtract-N-Amp tissue genomic DNA extraction kit according to the 
manufacturer’s instructions- except that volumes are 5-fold reduced. Perform PCR on 
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the extracted DNA as described in step 60 ; homozygous mosquitoes should be attL 
and attR positive but attP negative. 
64.   Set up inter-crosses with G3 homozygous adult mosquitoes and blood-feed to obtain 
a homozygous line in G4.  
65. Check that the line is homozygous in subsequent generations by fluorescence and by 
PCR.  
 
TROUBLESHOOTING  
Troubleshooting advice is provided in Table 2. 
 
Table 2. Troubleshooting 
Step Problem Possible reason Solution 
Step 42 The embryos 
loose too much 
yolk 
Embryos are not desiccated 
enough 
 
 
 
Too much mix is being 
injected 
Dry well the paper against 
the eggs after alignment 
before adding NaCl or 
halocarbon oil 
 
Decrease Pi or Ti 
 
   
 
 
 
 
 
The embryos are 
difficult to 
penetrate because 
they are soft or 
“rubbery” in 
texture 
 
 
The needle tip is too large 
 
The eggs are too young 
 
 
Embryos have been over 
desiccated  
 
Embryos are too old 
 
 
 
  
Replace the needle 
 
Wait the eggs become grey 
before aligning 
 
Rehydrate more quickly the 
eggs after desiccation  
 
Inject a  new batch of eggs  
 Needles clog 
continuously 
 
 
 
 
 
The mix may contain 
particulates. 
 
 
Embryos may need more 
desiccation 
 
 
Centrifuge the mix at top 
speed 5 min before 
pipetting 
 
Dry well the paper against 
the eggs after alignment 
before adding NaCl or 
halocarbon oil 
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Step 45 Hatching G0 
larvae stuck in 
the egg case 
Too much pressure is 
applied when transferring 
the aligned embryos onto 
the coverslip 
Apply less pressure when 
transferring the aligned 
embryos onto the coverslip 
 
Step 47 
 
Few transient 
fluorescent G0 
larvae are found  
 
The injection mix is not 
enough concentrated 
 
The mix does not enter in 
embryo cells 
 
Ensure the injection mix is 
correct 
 
Attempt injecting into the 
yolk, rather than into the 
periplasmic space 
 
  Weak transient 
fluorescence in 
G0 larvae 
The injection mix is not 
concentrated enough 
 
Increase the concentration 
of the injected plasmid 
DNA 
 
Step 56 
 
No transformants 
when the G0 
transient 
fluorescence was 
weak 
 
 
Not enough nucleic acids 
are delivered to embryos 
 
 
Control the quality of the 
mix. Increase nucleic acid 
concentration of the 
injection mix 
 
 No transformants 
when the G0 
transient 
fluorescence was 
good 
The rearing conditions are 
not optimal 
 
 
 
 
The transgene may be toxic 
Control your rearing 
conditions to maximize 
mosquito survival and 
fecundity 
 
 
Attempt injecting a neutral 
transgene 
 
TIMING 
Steps 1-7, Preparation of plasmid DNA carrying the transgene: 3 d 
Step 8, Preparation of DNA injection mix if using self-docking strains or helper plasmid: 
Optional 
Steps 9-23, mRNA phiC31 integrase synthesis: 4-6 d 
Steps 24-31, Preparation of DNA-mRNA mix for injection: 1-2 d 
Step 32-44, Embryo alignment and microinjection: 4-8 d 
Steps 45-48, Rearing injected embryos and screening transient fluorescence: 10 d 
Step 49-54, Rearing, crosses of G0 adults and progeny: 1 m 
Step 55-57, Screening G1 transgenic larvae: 4-6 d 
Step 58-65, Establishment of homozygous transgenic lines : 2 m 
 
ANTICIPATED RESULTS 
Using this protocol with the standard docking strain E (see Table 1), injection of roughly 2000 
embryos should be sufficient to produce a transgenic line (assuming no toxicity of the 
expressed transgene), with a mean embryo survival rate of approximately 25%. This can be 
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achieved in 2-4 days of injections, depending on the experience of the injector and the help of 
a second person to align the eggs. With the self-docking strains, injection of 1000 to 1500 
embryos is usually sufficient for obtaining a transgenic line with an embryo survival rate 
around 55 to 60%. Overall, the production of a single transgenic line will take roughly two to 
three months. However, injecting two different transgenic constructs in parallel over one-two 
weeks is manageable. This will allow two transgenic lines to be obtained almost 
simultaneously two-three months later.  
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FIGURE LEGENDS 
Figure 1. Schematic representation of phiC31 site-specific transformation in An. 
gambiae. (A) Description of the initial phase to create standard docking strains containing an 
attP site in their genome. In An. gambiae, these strains have been produced by co-injecting the 
piggyBac transposase helper plasmid and a piggyBac transposon containing an attP site and a 
ECFP fluorescent marker gene under the control of the eye /nervous system-specific 3xP3 
promoter. (B) The second phase is injecting into attP-containing embryos a plasmid 
containing an attB site, a fluorescent marker gene different from the one in the docking strain 
and the transgene along with a source for phiC31 integrase to mediate site-specific 
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recombination at the attP site. After recombination, attL and attR sites, insensitive to the 
integrase, are formed. As outlined in the main text, the source of integrase can be in vitro 
transcribed mRNA33 or a helper plasmid (A. L., unpublished). In recently developed self-
docking strains41 the integrase is produced in the attP-containing embryo germ-line, and only 
the attB plasmid is injected into the embryos. 
 
Figure 2. Fluorescent profile of larvae from standard docking strain and self-docking 
strain. (A) 4th instar larva of a standard docking strain associated with ECFP under control of 
the 3xP3 promoter33. (B) Larva of a self-docking strain associated with dsRed2 fluorescent 
marker under control of the constitutive promoter IE141.  
Figure 3. Timeline and flow diagram for site-specific phiC31 transformation in An. 
gambiae mosquitoes. Timing and steps for the procedure are outlined whether using a 
standard docking strain or a self-docking strain.  
Figure 4. Oviposition chamber. The bottom of a 50 ml polypropylene tube has been cut and 
covered by a dental dam with a slot to introduce mosquitoes. The inverted orange cap is half-
filled with deionized water to allow females to oviposit. 
Figure 5. G1 screening system. About two hundred 3rd to 4th instar larvae are transferred on 
a cellulose paper on top of a wet sponge. The paper is then transferred to a Petri dish for 
fluorescence screening. 
Figure 6. G0 larvae expressing transient fluorescence. Embryos of the standard docking 
strain E (see Table 1) were injected with attB plasmids encoding (A) EYFP, or (B) 
DsRed2nls, each under control of the 3xP3 promoter. As the nucleic acids are injected into the 
posterior end of embryos, only the posterior cells where 3xP3 expression occurs are 
fluorescent in hatching larvae. 
Figure 7. False positive G1 larvae. G0 embryos of an ECFP docking strain were injected 
with an attB plasmid containing EYFP under the control of the 3xP3 promoter. Some G1 
larvae from G0 females express the EYFP screening marker in one eye (A) or two eyes (C), 
while the ECFP marker of the docking strain, also under the control of the 3xP3 promoter, is 
well expressed from eyes to anal papillae (B, D).  
 
Table 1. Anopheles gambiae phiC31 docking strains and self-docking strains. This table 
provides the list of docking strains that are available for phase 2 integration. The name of the 
lines, chromosomal and genomic location (on the reference of PEST scaffolds) of the attP 
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insertion, associated promoter and fluorescent marker are shown (see references  33,41 for 
details). 
 
Docking 
strain 
PhiC31 source Chromosome
Chromosomal 
location 
Associated 
marker 
Tested for 
phase 2 
E Injected  III 3R 31B 15801959 3P3-ECFP yes 
G Injected  II 2L 22E 18922078 3P3-ECFP no 
H Injected  II 2L 20A 1316139 3P3-ECFP no 
F Germ-line II 2L 23C 23661650 IE1-DsRed2 yes 
Q Germ-line III 3L41A 15200903 IE1-DsRed2 yes 
 
 
Table S1. Primers and PCR parameters to detect transgene site-specific integration. 
 
Supplementary Video 1. Anopheles gambiae embryo alignment for microinjection. 
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